These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 1016340)

  • 1. Evaluating drugs and determining the drug needs of developed and developing countries.
    Stolley PD
    J Community Health; 1976; 2(2):113-20. PubMed ID: 1016340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Problems in assessing rationality of drug utilization in less developed countries.
    Ali HM
    Acta Med Scand Suppl; 1988; 721():27-30. PubMed ID: 3162632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug use and the role of patients and prescribers.
    Sterky G; Tomson G; Diwan VK; Sachs L
    J Clin Epidemiol; 1991; 44 Suppl 2():67S-72S. PubMed ID: 2045844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulatory differences and similarities: systems in Japan.
    Sakuma A
    Clin Pharmacol Ther; 1976 May; 19(5 Pt 2):694-9. PubMed ID: 1269210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Field tests for rational drug use in twelve developing countries.
    Hogerzeil HV; Bimo ; Ross-Degnan D; Laing RO; Ofori-Adjei D; Santoso B; Azad Chowdhury AK; Das AM; Kafle KK; Mabadeje AF
    Lancet; 1993 Dec; 342(8884):1408-10. PubMed ID: 7901689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The multinational drug companies in Zaire: their adverse effect on cost and availability of essential drugs.
    Glucksberg H; Singer J
    Int J Health Serv; 1982; 12(3):381-7. PubMed ID: 7118328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using perinatal audit to promote change: a review.
    Mancey-Jones M; Brugha RF
    Health Policy Plan; 1997 Sep; 12(3):183-92. PubMed ID: 10173399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of essential drugs in rural Ghana.
    Hogerzeil HV
    Int J Health Serv; 1986; 16(3):425-40. PubMed ID: 3089956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Evaluation of prescription practices and of the rational use of medicines in Niger].
    Mallet HP; Njikam A; Scouflaire SM
    Sante; 2001; 11(3):185-93. PubMed ID: 11641083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postmarketing surveillance in developing countries.
    Meirik O
    Netw Res Triangle Park N C; 1988; 9(2):6. PubMed ID: 12280953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of the anatomical chemical system/defined daily doses: Challenges and way forward for resource-limited countries.
    Nantongo H; Batwaala V; Nambasa V; Mukonzo JK
    J Clin Pharm Ther; 2022 Feb; 47(2):135-138. PubMed ID: 34254326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The rationale for a post-marketing surveillance.
    Westerholm B
    Hum Reprod; 1987 Jan; 2(1):41-4. PubMed ID: 3571446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Providing safe medicines for children in Nigeria: The impediments and remedies.
    Oshikoya KA; Senbanjo IO
    Ann Afr Med; 2010; 9(4):203-12. PubMed ID: 20935418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ten recommendations to improve use of medicines in developing countries.
    Laing R; Hogerzeil H; Ross-Degnan D
    Health Policy Plan; 2001 Mar; 16(1):13-20. PubMed ID: 11238425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advertisements for medicines in leading medical journals in 18 countries: a 12-month survey of information content and standards.
    Herxheimer A; Lundborg CS; Westerholm B
    Int J Health Serv; 1993; 23(1):161-72. PubMed ID: 8425785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relation between drug utilization and morbidity. A record linkage study.
    Skegg DC
    Acta Med Scand Suppl; 1984; 683():81-7. PubMed ID: 6588742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reducing drug therapy-induced hospitalization: impact of drug utilization review.
    Morse ML; Leroy AA; Gaylord TA; Kellenberger T
    Drug Inf J; 1982; 16(4):199-202. PubMed ID: 10260023
    [No Abstract]   [Full Text] [Related]  

  • 19. Drug utilization and morbidity statistics for the evaluation of drug safety in Sweden.
    Wiholm BE; Westerholm B
    Acta Med Scand Suppl; 1984; 683():107-17. PubMed ID: 6430038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Developing an open relationship with the drug industry.
    Vallance P
    Lancet; 2005 Sep 24-30; 366(9491):1062-4. PubMed ID: 16182883
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.